Tag: Stem Cells
Overall Survival Improving for Umbilical Cord Blood Transplant
Inferior overall survival seen in Latine adults compared with Black patients in a multivariable analysis
Non-Hispanic Black Patients Have Disparities in HCT Use for Hematologic Cancers
For AML and MDS, lower utilization seen for non-Hispanic Black patients compared with other groups
Lung Function Stable Three Years After Hematopoietic Cell Transplant in Sickle Cell
Improvement seen in diffusing capacity of the lungs for carbon monoxide and in the six-minute walk test
FDA Approves Darzalex Faspro for Treating Multiple Myeloma
The quadruplet regimen was approved for stem cell transplant-eligible patients
Socioeconomic Status of Stem Cell Donor Affects Recipient Health Outcomes
Recipients receiving cells from donors in lowest quartile of SES experienced reduction in overall survival, increase in treatment-linked mortality
Successful Pregnancy Possible for Stem Cell Transplant Recipients
Annual first birth rate 0.45 percent, which was more than six times lower than in general population
Posttransplant Cyclophosphamide GVHD Prophylaxis Beneficial in Leukemia
PTCy GVHD prophylaxis after allogeneic stem cell transplant yields comparable relapse incidence, lower GVHD
Mesenchymal Stem Cell-Neural Progenitors Beneficial for MS
More improvement in timed 25-foot walk, six-minute walk test seen among those requiring assistance for ambulation
Positive Psychology Intervention Aids Allogeneic Stem Cell Transplant Survivors
Greater improvements reported in gratitude, anxiety, physical function at nine weeks; more improvements seen at 18 weeks
Hematopoietic Cell Transplantation Use Has Increased for All Racial Groups
Rates of increase significantly higher for Hispanics and non-Hispanic African Americans for autologous, allogeneic HCT
